Pear Therapeutics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Pear Therapeutics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10495
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD) in conjunction with opioid replacement therapy; Thrive designed for schizophrenia; reCALL using virtual reality exposure therapy to treat combat posttraumatic stress disorder (PTSD); reVIVE against general anxiety disorder; and PEAR-005 to PEAR-011 for treating pain, major depressive disorder, insomnia, Parkinson’s disease and inflammatory conditions. Pear Therapeutics reSET, is an FDA-authorized prescription therapeutic for substance use disorder (SUD) used as an outpatient treatment. The company works in partnership with Center for Technology and Behavioral Health, Dartmouth College, Ehave, Inc., Intellectual Ventures Management LLC, Novartis AG, and others. Pear Therapeutics is headquartered in Boston, Massachusetts, the US.

Pear Therapeutics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pear Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pear Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Pear Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pear Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Pear Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Pear Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Pear Therapeutics Raises USD50 Million in Series B Financing 10
Pear Therapeutics Raises USD20 Million in Equity Financing Round 12
Pear Therapeutics Raises Additional Funds through Venture Financing 13
Pear Therapeutic Raises Funds Through Crowdfunding 14
Partnerships 15
Pear Therapeutics Enters into Agreement with Sandoz 15
Pear Therapeutics Enters into Agreement with Novartis 16
Pear Therapeutics Inc – Key Competitors 17
Pear Therapeutics Inc – Key Employees 18
Pear Therapeutics Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Pear Therapeutics Inc, Medical Equipment, Key Facts 2
Pear Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Pear Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pear Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Pear Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pear Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Pear Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Pear Therapeutics Raises USD50 Million in Series B Financing 10
Pear Therapeutics Raises USD20 Million in Equity Financing Round 12
Pear Therapeutics Raises Additional Funds through Venture Financing 13
Pear Therapeutic Raises Funds Through Crowdfunding 14
Pear Therapeutics Enters into Agreement with Sandoz 15
Pear Therapeutics Enters into Agreement with Novartis 16
Pear Therapeutics Inc, Key Competitors 17
Pear Therapeutics Inc, Key Employees 18
Pear Therapeutics Inc, Other Locations 19

List of Figures
Pear Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Pear Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Pear Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Pear Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Pear Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pear Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Pear Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pear Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Pear Therapeutics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Zoomlion Heavy Industry Science and Technology Co., Ltd.:戦略・SWOT・企業財務分析
    Zoomlion Heavy Industry Science and Technology Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Zoomlion Heavy Industry Science and Technology Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the comp …
  • iBio Inc (IBIO):企業の財務・戦略的SWOT分析
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It has its applications in ibiolaunch platform, which is a transformative technology for the production of monoclo …
  • Reata Pharmaceuticals Inc (RETA):製薬・医療:M&Aディール及び事業提携情報
    Summary Reata Pharmaceuticals Inc (Reata) is a clinical-stage biopharmaceutical company that develops innovative medicines for the treatment of serious and life-threatening diseases. The company’s clinical candidates include bardoxolone methyl and omaveloxolone, which target Nrf2, a transcription fa …
  • McKesson Corp (MCK)-医療機器分野:企業M&A・提携分析
    Summary McKesson Corp (McKesson) is a provider of healthcare services and information technology solutions. It distributes ethical and proprietary drugs and equipment and health and beauty care products in North America and overseas. The company also develops and provides decision support software a …
  • ThyssenKrupp AG:企業の戦略・SWOT・財務情報
    ThyssenKrupp AG - Strategy, SWOT and Corporate Finance Report Summary ThyssenKrupp AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • FPT Industrial SpA:企業の戦略的SWOT分析
    FPT Industrial SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Sinopharm Group Co Limited:企業の戦略・SWOT・財務分析
    Sinopharm Group Co Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopharm Group Co Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Sarossa plc:企業の戦略的SWOT分析
    Sarossa plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Barclays Bank of Kenya Ltd:企業の戦略・SWOT・財務分析
    Barclays Bank of Kenya Ltd - Strategy, SWOT and Corporate Finance Report Summary Barclays Bank of Kenya Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Hitachi Capital (UK) PLC:企業の戦略・SWOT・財務情報
    Hitachi Capital (UK) PLC - Strategy, SWOT and Corporate Finance Report Summary Hitachi Capital (UK) PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • CH2M HILL Companies, Ltd.:企業の戦略・SWOT・財務情報
    CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report Summary CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ingram Micro Inc.:企業の戦略・SWOT・財務情報
    Ingram Micro Inc. - Strategy, SWOT and Corporate Finance Report Summary Ingram Micro Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • TE Connectivity Ltd (TEL):企業の財務・戦略的SWOT分析
    TE Connectivity Ltd (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • NACHI-FUJIKOSHI CORP.:企業の戦略・SWOT・財務情報
    NACHI-FUJIKOSHI CORP. - Strategy, SWOT and Corporate Finance Report Summary NACHI-FUJIKOSHI CORP. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Brightside Group:企業の戦略・SWOT・財務情報
    Brightside Group - Strategy, SWOT and Corporate Finance Report Summary Brightside Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sumitomo Metal Mining Co Ltd:戦略・SWOT・企業財務分析
    Sumitomo Metal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Metal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Exelon Corporation:企業の戦略・SWOT・財務情報
    Exelon Corporation - Strategy, SWOT and Corporate Finance Report Summary Exelon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Tupperware Brands Corporation:企業の戦略・SWOT・財務情報
    Tupperware Brands Corporation - Strategy, SWOT and Corporate Finance Report Summary Tupperware Brands Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Blueprint Medicines Corp (BPMC)-医療機器分野:企業M&A・提携分析
    Summary Blueprint Medicines Corp (Blueprint) is a biotechnology company that develops drugs for the treatment of cancers. The company discovers selective kinase inhibitors for genomically defined cancer subsets. Its pipeline products include BLU-285, for treatment resistant gastrointestinal stromal …
  • Freestone Resources Inc (FSNR):企業の財務・戦略的SWOT分析
    Summary Freestone Resources Inc (Freestone Resources) is an oilfield technology company that offers unconventional and conventional oil recovery solutions. The company offers petrozene solvent. Its petrozene solvent offers solutions in operations of tanker sludge, sediment and water, tar residue and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆